Apocrine Carcinomas Are a Distinct Subset of Androgen Receptor Positive (AR plus ) Triple Negative Breast Carcinomas (TNBC)

被引：0
|
作者：
Astvatsaturyan, Kristine [1 ]
Yue, Yong [1 ]
Bose, Shikha [1 ]
机构：
[1] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
来源：
LABORATORY INVESTIGATION | 2017年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
108
引用
收藏
页码：30A / 30A
页数：1
相关论文
共 50 条
  • [21] Integration of Androgen Receptor (AR) Expression to Predict Survival for Triple-Negative Breast Carcinoma (TNBC)
    Astvatsaturyan, Kristine
    Yue, Yong
    Bose, Shikha
    MODERN PATHOLOGY, 2016, 29 : 30A - 30A
  • [22] Androgen receptor (AR): A novel target and mechanism for radiosensitization and treatment in triple negative breast cancers (TNBC)
    Speers, C.
    Zhao, S. G.
    Liu, M.
    Rae, J. M.
    Hayes, D. F.
    Feng, F. Y.
    Pierce, L. J.
    CANCER RESEARCH, 2016, 76
  • [23] Distant recurrences in triple negative breast cancer (TNBC) according to androgen receptor (AR) status.
    Tung, Nadine M.
    Garber, Judy Ellen
    Hacker, Michele R.
    Torous, Vanda
    Nalven, Tessa
    Alexander, Brian Michael
    Lee, Larissa Janeen
    Collins, Laura C.
    Schnitt, Stuart J.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [24] Androgen receptor (AR): A novel target for radiosensitization and treatment in triple-negative breast cancers (TNBC)
    Speers, Corey
    Zhao, Shuang G.
    Liu, Meilan
    Evans, Joseph
    Alluri, Prasanna
    Hayes, Daniel F.
    Feng, Felix Y.
    Pierce, Lori J.
    CANCER RESEARCH, 2015, 75
  • [25] Integration of Androgen Receptor (AR) Expression to Predict Survival for Triple-Negative Breast Carcinoma (TNBC)
    Astvatsaturyan, Kristine
    Yue, Yong
    Bose, Shikha
    LABORATORY INVESTIGATION, 2016, 96 : 30A - 30A
  • [26] Differences in Gene Expression Between Androgen Receptor Positive and Negative Triple Negative (EFt/PR/Her2) Breast Carcinomas
    Ghazalpour, A.
    Basu, G.
    Bender, R.
    Gatalica, Z.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 147 - 147
  • [27] IMP3, a novel basal phenotype marker, is commonly overexpressed in triple negative adenoid cystic carcinomas of the breast but not in triple negative apocrine carcinomas
    Vranic, S.
    Frkovic-Grazio, S.
    Palazzo, J.
    Gatalica, Z.
    HISTOPATHOLOGY, 2010, 57 : 26 - 27
  • [28] Prognosis in triple-negative apocrine carcinomas of the breast: A population-based study
    Wu, Wenyu
    Wu, Meiying
    Peng, Guowen
    Shi, Degang
    Zhang, Jian
    CANCER MEDICINE, 2019, 8 (18): : 7523 - 7531
  • [29] ANDROGEN RECEPTOR (AR) EXPRESSION AS A PROMISING INDEX OF THE PREDICTION OF DISTANT METASTASIS OF TRIPLE NEGATIVE BREAST CANCER (TNBC)
    Miwa, Noriko
    Onishi, Takahito
    Nakamura, Seigo
    BREAST, 2015, 24 : S73 - S73
  • [30] Androgen receptor (AR) expression in 400 breast carcinomas: is routine AR assessment justified?
    Safarpour, Damoun
    Pakneshan, Shabnam
    Tavassoli, Fattaneh A.
    AMERICAN JOURNAL OF CANCER RESEARCH, 2014, 4 (04): : 353 - U61
12345